Companies / Virica Biotech
Virica Biotech
Company
Virica Biotech develops and provides small molecule cell enhancers called Viral Sensitizers to improve manufacturing productivity and reduce costs in cell and gene therapies
Virica Biotech has 1 investor on file, among them Dynamk Capital. Its site was last checked 6 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Dynamk Capital
10 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See Dynamk Capital's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Virica Biotech and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Dynamk Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/viricabiotech.com/investors
# also
GET /v1/companies/viricabiotech.com
GET /v1/companies/viricabiotech.com/news